VAT65: Antitetanus Vaccination for People Older Than 65 Years.

• Sponsor: Hospices Civils de Lyon (Other)
• Overall Status: Completed
• CT.gov ID: NCT03266211
• Collaborator: (none)
• Enrollment: 261
• Location: 1
• Actual Duration (Months): 1.4
• Patients Per Site Per Month: 180.5

Study Details

Study Description

Brief Summary

In the last ten years, more than one hundred generalized tetanus cases were declared in France. Most of them were affecting people older than 70 years with an important mortality (around 28%). It is know that the only way to protect ourselves from this disease is the vaccination. In France tetanus vaccination is mandatory since 1940.

Nowaday none study looked specifically for the vaccination of people older than 65 years. The hypothesis is: there is a difference in the tetanus vaccination coverage for people older than 65 years depending on the demographic and medical practice of their general practitioner.

Condition or Disease	Intervention/Treatment	Phase
Tetanus	Other: Questionnaire Patients; Other: Questionnaire General practitioner

Study Design

• Study Type: Observational
• Actual Enrollment: 261 participants
• Observational Model: Other
• Time Perspective: Prospective
• Official Title: Antitetanus Vaccination for People Older Than 65 Years in the Auvergne-Rhône-Alpes (France) Region Depending on the Demographic and Medical Practice of Their Medical Practitioner.
• Actual Study Start Date: Nov 9, 2017
• Actual Primary Completion Date: Dec 23, 2017
• Actual Study Completion Date: Dec 23, 2017

Arms and Interventions

Arm	Intervention/Treatment
Patients People older than 65 years in the Auvergne-Rhônes-Alpes region who are consulting their general practitioner.	Other: Questionnaire Patients; Patient will have to answer a quiz which is about their vaccination against tetanus.
General practitioner General practitioner of the Auvergne-Rhônes-Alpes region	Other: Questionnaire General practitioner; General practitioner will have to answer a quiz which is about their medical practice concerning vaccination against tetanus.

Outcome Measures

Primary Outcome Measures

1. Tetanus vaccination coverage [About 5 minutes]

   Patient will have to answer a quiz which is about their vaccination against tetanus.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Patients older than 65 years consulting their attending physician in and who agreed to participate in the study.

• The doctors included are general practitioners located in a liberal office in the "Auvergne Rhône Alpes" region for which the URPS ("Union régional des Professionnels de Santé") has an email address.

Exclusion Criteria:

• None

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Service Urgence et Réanimation Pédiatrique Hôpital Femme Mère Enfant Groupement Hospitalier Est	Bron		France	69677

Sponsors and Collaborators

• Hospices Civils de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Hospices Civils de Lyon
• ClinicalTrials.gov Identifier: NCT03266211
• Other Study ID Numbers: 69HCL17_0375
• First Posted: Aug 30, 2017
• Last Update Posted: Jun 12, 2018
• Last Verified: Aug 1, 2017

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Tetanus

Study Results

No Results Posted as of Jun 12, 2018